Human Molecular Genetics, 2000, Vol. 9, No. 3 325-331
© 2000 Oxford University Press
Genetic variability in the regulatory region of presenilin 1 associated with risk for Alzheimer’s disease and variable expression
Flanders Interuniversity Institute for Biotechnology (VIB), Born-Bunge Foundation (BBS), University of Antwerp (UIA), Department of Biochemistry, Antwerpen, Belgium and 1Department of Epidemiology and Biostatistics, Erasmus University Medical School, 3000 DR Rotterdam, The Netherlands
Mutations in the presenilin 1 (PSEN1) gene have been implicated in 18–50% of autosomal dominant cases with early-onset Alzheimer’s disease (EOAD). Also, PSEN1 has been suggested as a potential risk gene in late-onset AD cases. We recently showed genetic association in a population-based study of EOAD, pointing to the 5' regulatory region of PSEN1. In this study we systematically screened 3.5 kb of the PSEN1 upstream region and found four novel polymorphisms. Genetic analysis confirmed association of two polymorphisms with increased risk for EOAD. In addition, we detected two different mutations in EOAD cases at –280 and –2818 relative to the transcription initiation site in exon 1A of PSEN1. Analysis of the mutant and wild-type –280 variants using luciferase reporter gene expression in transiently transfected neuroblastoma cells showed a 30% decrease in transcriptional activity for the mutant –280G PSEN1 promoter variant compared with the wild-type variant –280C. Our data suggest that the increased risk for EOAD associated with PSEN1 may result from genetic variations in the regulatory region leading to altered expression levels of the PSEN1 protein.
+ To whom correspondence should be addressed at: Laboratory of Molecular Genetics, Neurogenetics Group, University of Antwerp (UIA), Department of Biochemistry, Universiteitsplein 1, B-2610 Antwerpen, Belgium. Tel: +32 3 8202333; Fax: +32 3 8202541; Email: cruts@uia.ua.ac.be
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  G. Bourque, B. Leong, V. B. Vega, X. Chen, Y. L. Lee, K. G. Srinivasan, J.-L. Chew, Y. Ruan, C.-L. Wei, H. H. Ng, et al. Evolution of the mammalian transcription factor binding repertoire via transposable elements Genome Res., November 1, 2008; 18(11): 1752 - 1762. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. M. Stylianou, J. P. Affourtit, K. R. Shockley, R. Y. Wilpan, F. A. Abdi, S. Bhardwaj, J. Rollins, G. A Churchill, and B. Paigen Applying Gene Expression, Proteomics and Single-Nucleotide Polymorphism Analysis for Complex Trait Gene Identification Genetics, March 1, 2008; 178(3): 1795 - 1805. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. B.H. Williams, E. K.F. Chan, M. J. Cowley, and P. F.R. Little The influence of genetic variation on gene expression Genome Res., December 1, 2007; 17(12): 1707 - 1716. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Shen and R. J. Kelleher III The presenilin hypothesis of Alzheimer's disease: Evidence for a loss-of-function pathogenic mechanism PNAS, January 9, 2007; 104(2): 403 - 409. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Thomas and M. Fenech A review of genome mutation and Alzheimer's disease Mutagenesis, January 1, 2007; 22(1): 15 - 33. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Theuns, J. Remacle, R. Killick, E. Corsmit, K.'l Vennekens, D. Huylebroeck, M. Cruts, and C. V. Broeckhoven Alzheimer-associated C allele of the promoter polymorphism -22C>T causes a critical neuron-specific decrease of presenilin 1 expression Hum. Mol. Genet., April 15, 2003; 12(8): 869 - 877. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. COTSAPAS, E. CHAN, M. KIRK, M. TANAKA, and P. LITTLE Genetic Variation and the Control of Transcription Cold Spring Harb Symp Quant Biol, January 1, 2003; 68(0): 109 - 114. [Abstract] [PDF]
|
|
|
|
 |
|
 S. Leonard, J. Gault, J. Hopkins, J. Logel, R. Vianzon, M. Short, C. Drebing, R. Berger, D. Venn, P. Sirota, et al. Association of Promoter Variants in the {alpha}7 Nicotinic Acetylcholine Receptor Subunit Gene With an Inhibitory Deficit Found in Schizophrenia Arch Gen Psychiatry, December 1, 2002; 59(12): 1085 - 1096. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. S. Athan, J. H. Lee, A. Arriaga, R. P. Mayeux, and B. Tycko Polymorphisms in the Promoter of the Human APP Gene: Functional Evaluation and Allele Frequencies in Alzheimer Disease Arch Neurol, November 1, 2002; 59(11): 1793 - 1799. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. A. Rogaeva, K.C. Fafel, Y.Q. Song, H. Medeiros, C. Sato, Y. Liang, E. Richard, E.I. Rogaev, P. Frommelt, A. D. Sadovnick, et al. Screening for PS1 mutations in a referral-based series of AD cases: 21 Novel mutations Neurology, August 28, 2001; 57(4): 621 - 625. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-C. Lambert, D. M A Mann, J. M Harris, M.-C. Chartier-Harlin, A. Cumming, J. Coates, H. Lemmon, D. StClair, T. Iwatsubo, and C. Lendon The {-}48 C/T polymorphism in the presenilin 1 promoter is associated with an increased risk of developing Alzheimer's disease and an increased A{beta} load in brain J. Med. Genet., June 1, 2001; 38(6): 353 - 355. [Abstract] [Full Text]
|
|
|
|
|
|
M. J Houseman, L. A Ellis, A. Pagnamenta, W.-L. Di, S. Rickard, A. H Osborn, H.-H. M Dahl, G. R Taylor, M. Bitner-Glindzicz, W. Reardon, et al. Genetic analysis of the connexin-26 M34T variant: identification of genotype M34T/M34T segregating with mild-moderate non-syndromic sensorineural hearing loss J. Med. Genet., January 1, 2001; 38(1): 20 - 25. [Abstract] [Full Text]
|
|
|
|
|
|
J. Theuns and C. Van Broeckhoven Transcriptional regulation of Alzheimer's disease genes: implications for susceptibility Hum. Mol. Genet., October 1, 2000; 9(16): 2383 - 2394. [Abstract] [Full Text] [PDF]
|
|